Skip to main content

Author: Linxi Mytkolli

Annonce des récipiendaires des bourses d’Action diabète Canada (2017-18)

Written by Linxi Mytkolli on . Posted in News - French.

 

  1. Bourses du Groupe de travail de la formation et du mentorat 2017-2018
  2. Bourses du Groupe de travail sur le transfert de connaissances 2017-2018

 

Bourses du Groupe de travail de la formation et du mentorat 2017-2018

Cette année, le Groupe de travail de la formation et du mentorat accordera quatre bourses en mentorat de

10 000 $ pour une période d’un an ainsi que qu’une bourse postdoctorale, évaluée par les pairs à Diabète Canada, d’une valeur de 50 000 $ par année pour une période de deux ans.

Nous sommes heureux d’annoncer les récipiendaires et ses affiliations pour les bourses en Recherche axée sur le patient – Mentorat des jeunes chercheurs en diabète et ses complications et la bourse postdoctorale 2017-2018 :

Récipiendaires de la bourse de mentorat

1- Laura Desveaux – Institute for Health System Solutions and Virtual Care, Women’s College Hospital

2- Martin Sénéchal – Faculty of Kinesiology, University of New Brunswick

3- Marie-Claude Tremblay – Faculté de médecine, Université Laval

4- Xiaolin Wei – Dalla Lana School of Public Health, University of Toronto

Stagiaire postdoctorale

1- Priska Stahel – Toronto General Hospital Research Institute

 

Bourses du Groupe de travail sur le transfert de connaissances 2017-2018

Cette année, le Groupe de travail sur le transfert de connaissances d’Action diabète Canada accordera quatre bourses pour une période d’un an.

Les récipiendaires des bourses du Groupe de travail sur le transfert de connaissances 2017-2018 sont :

 Étudiantes graduées

1-      Selena Davis – School of Health Information Science, University of Victoria

Superviseur : Abdul Roudsari

2-      Ghazal Fazli – Institute of Health Policy Management and Evaluation, University of Toronto

Superviseure : Gillian L. Booth

 Stagiaires postdoctoraux

1-      Ruth Ndjaboue – Faculté de médecine, Université Laval

Superviseure : Holly O. Witteman

2-      Séraphin-Guy Balla Ndegue – Faculté de médecine, Université Laval

Superviseures : Maman Joyce Dogba/Monika Kastner

 

Félicitations et bon succès à tous les récipiendaires des bourses d’Action diabète Canada 2017-2018!

Announcement of Recipients of Diabetes Action Canada Awards (2017-18)

Written by Linxi Mytkolli on . Posted in News. No Comments on Announcement of Recipients of Diabetes Action Canada Awards (2017-18)

 

  1. Training and Mentorship Group Mentorship and Fellowship Awards 2017-2018
  2. Knowledge Translation Group Scholarships Awards 2017-2018

 

Training and Mentorship Group Mentorship and Fellowship Awards 2017-2018

This year, the Diabetes Action Canada Training and Mentoring Group will be granting four Mentorship Awards of $10,000 for a period of one year and one Post-doctoral Fellowship Award, peer-reviewed by Diabetes Canada, of $50,000/year for a period of two years.

We are pleased to announce the successful recipients of the 2017-18 Patient-Oriented Research Early Career Investigator Mentorship Awards and the Post-doctoral Fellowship Award and their affiliations:

 Mentorship Awardees

1- Laura Desveaux – Institute for Health System Solutions and Virtual Care, Women’s College Hospital

2- Martin Sénéchal – Faculty of Kinesiology, University of New Brunswick

3- Marie-Claude Tremblay – Faculté de médecine, Université Laval

4- Xiaolin Wei – Dalla Lana School of Public Health, University of Toronto

Post-doctoral Fellowship Awardee

1- Priska Stahel – Toronto General Hospital Research Institute

 

Knowledge Translation Group Scholarships Awards 2017-2018

This year, the Diabetes Action Canada Knowledge Translation Group will be granting four scholarships awards for a period of one year.

We are pleased to announce the awardees for the scholarships awards for graduate students and post-doctoral fellows 2017-2018.

DAC KT scholarships Award recipients are:

 Graduate students

1-      Selena Davis – School of Health Information Science, University of Victoria

Supervisor: Abdul Roudsari

2-      Ghazal Fazli – Institute of Health Policy Management and Evaluation, University of Toronto

Supervisor: Gillian L. Booth

Post-doctoral fellows

1-      Ruth Ndjaboue – Faculté de médecine, Université Laval

Supervisor: Holly O. Witteman

2-      Séraphin-Guy Balla Ndegue – Faculté de médecine, Université Laval

Supervisors : Maman Joyce Dogba/Monika Kastner

 

Congratulations and best of luck to all awardees of Diabetes Action Canada Awards 2017-2018!

16TH ANNUAL KEEPING THE FIRES BURNING

Written by Linxi Mytkolli on . Posted in News, News - French. No Comments on 16TH ANNUAL KEEPING THE FIRES BURNING

We are delighted to announce that Clarence Nepinak was honoured at the 16th Annual Keeping the  Fires Burning event.

Clarence Nepinak was selected by Aboriginal Council of Winnipeg for his lifetime contribution to the well being of the First Nations people and communities.

Keeping the Fires Burning was started in 2001. Over the past 16 years, Ka Ni Kanichihk has honored 113 First Nations, Metis and Inuit grandmothers and grandfathers- all of whom have made a significant contribution to the advancement of Indigenous peoples, and, indeed, the safeguarding, nurturing and transmission of Traditional Knowledge and practice. Our Grandmothers and Grandfathers are the holders of our histories- the keepers of our traditional knowledge of ” our link to Mino Bimaadiziiwin”.

Review of MedsCheck Diabetes Program in Ontario

Written by Linxi Mytkolli on . Posted in News. No Comments on Review of MedsCheck Diabetes Program in Ontario

 

 

 

Review of MedsCheck Diabetes Program in Ontario

(Thursday, April 6, 2017 – Toronto, ON) – There are more than 2 million Canadians currently living with diabetes, costing the healthcare system 13.1 billion dollars a year. It is the leading cause of adult onset blindness, kidney disease, and non-traumatic lower limb amputations, and diabetes patients are two to four times more likely to die of cardiovascular disease than those without diabetes.

In 2010, the Ontario Ministry of Health and Long-Term Care introduced the MedsCheck Diabetes program to help patients better understand their medication therapy and ensure their medications are taken as prescribed. Conducted by community pharmacists, these annual medication reviews promote healthier patient outcomes and self-management of the disease, improve and optimize drug therapy and lifestyle, and ensure the safe, effective, and appropriate use of all types of medications, medication devices, and supplies.
Researchers from the University of Toronto, McMaster University, and the Ontario Pharmacy Evidence Network (OPEN) have published the findings of a four-year review of the MedsCheck Diabetes program in the Canadian Journal of Diabetes.

Recognizing that medications play a vital role in reducing the development and progression of diabetes complications, the researchers were interested to see if the MedsCheck Diabetes program was accessed by patients, develop a composite of who those patients are, and determine whether or not they took advantage of it annually.

Using administrative claims data for Ontario held by the Institute for Clinical Evaluative Sciences, they discovered that roughly half of Ontarians with diabetes received a MedsCheck Diabetes review between 2010 and 2014. However, only 4.1% of recipients 66 years of age or older and 2.7% of recipients younger than 66 years of age received a MedsCheck Diabetes follow-up over the same period.

“Through our analysis, it was encouraging to confirm that almost half of Ontarians with diabetes had received this specialized pharmacist consultation, indicating that pharmacists are ready to deliver this type of care to diabetes patients. One surprising finding, however, was that we observed a very low number of follow-up visits despite this being part of the original program,” noted Dr. Lori MacCallum, Sun Life Financial Professor of Wellness and Diabetes Education at the Banting & Best Diabetes Centre and Assistant Professor at the Leslie Dan Faculty of Pharmacy, University of Toronto, lead author of the paper. “This is concerning given the chronic nature of diabetes and the complexity of patients receiving the annual review. One would think that follow-up visits would be necessary and desired to ensure continuity of quality care.”

The study revealed a great deal about the patients that are accessing this service, including that recipients 66 years of age and older were on an average of 11 different medications over a one year period before they received a MedsCheck Diabetes review, many of which were high-risk medications like blood thinners, benzodiazepines, and narcotics that are known to cause significant adverse effects in the elderly. In addition, over one-third of MedsCheck Diabetes recipients (33.5%) had a diabetes-related emergency room visit or hospitalization in the year prior to their MedsCheck Diabetes review.

“This study provides a solid foundation for understanding how MedsCheck Diabetes reviews have been utilized since their introduction,” said Dr. MacCallum. “Now, however, we need to continue this research to understand the benefit they provide to patients and the healthcare system, and discover what the enablers and impediments are that influence how this service is offered by pharmacists and accessed by patients.”

This study was funded by a grant from the Ministry of Health and Long-Term Care through the Ontario Pharmacy Evidence Network.

 

For more information, please contact:

Dr. Lori MacCallum
Sun Life Financial Professor of Wellness and Diabetes Education
Banting & Best Diabetes Centre
Faculty of Medicine
Assistant Professor, Leslie Dan Faculty of Pharmacy
University of Toronto
(416) 340-4800 Ext. 2784
lori.maccallum@uhnresearch.ca

Career Development Awards- Juvenile Diabetes Research Foundation International

Written by Linxi Mytkolli on . Posted in News. No Comments on Career Development Awards- Juvenile Diabetes Research Foundation International

 

Career Development Awards- Juvenile Diabetes Research Foundation International

May 15, 2017 • Reply to Christine Kwan

The JDRF’s Career Development Award is a five-year term award, where awardees will focus their research efforts on a subject directly related to JDRF mission goals and research priorities, and position themselves to work at the leading edge of type 1 diabetes research. These awards are designed to assist exceptionally promising investigators. Although JDRF is especially interested in fostering careers in clinical investigation, Career Development Awards may emphasize either basic or clinical topics.

Applicant Eligibility
Required: MD, DMD, DVM, PhD, or equivalent and faculty position or equivalent. This program is intended for individuals at an early stage of their independent academic career. Researchers who have received their first faculty-level appointment less than 3 years before the submission date are eligible to apply for this award. The applicant must hold an academic faculty-level position (including assistant professor or equivalent) at the time of submission of the proposal, at a university, health science center, or comparable institution with strong, well-established research and training programs for the chosen area of interest

Proposal & Submission Process
Access and submit full applications (including research plans) via RMS360. By the internal deadline, applicants are required to have routed their application via RMS360 to the Research Office for review, approval and submission.  In addition, applicants are required to submit their application, in advance of the internal deadline, through the University’s My Research System for institutional approval.

Terms

150,000 USD maximum/year for up to 5 years, including up to 10% for indirect costs

Internal Deadline: June 23, 2017

Sponsor Deadline: June 28, 2017

For more information on the funding opportunity, please click here